SeaStar Medical CMO Kevin Chung presents at pediatric extracorporeal therapy symposium
PUBT · 1d ago
Share
Listen to the news
- SeaStar Medical’s Chief Medical Officer Kevin Chung will present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium in Houston.
- Conference runs Oct. 6-8, 2026, hosted by Texas Children’s Hospital.
- Chung is scheduled to speak Tuesday, Oct. 6, 2026, 8:30-10:00 a.m. CDT in a pediatric extracorporeal therapies innovation session.
- Talk will highlight QUELIMMUNE, SeaStar’s extracorporeal therapy for critically ill pediatric patients with acute kidney injury.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290836PRIMZONEFULLFEED9835682) on September 29, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending